A gastroscopic method of implanting a device for treating obesity of a patient by the device being postoperatively and non-invasively regulated to actively stretch a portion of the stomach wall of the patient to actively create a feeling of satiety. The method comprising the steps of: inserting the stretching device into the stomach of the patient through the esophagus, inserting the operation device into the body of the patient, the operation device being adapted to be connected to the stretching device, placing the stretching device in contact with the stomach wall, and fixating the stretching device to the stomach wall such that the operation device can regulate the device for actively stretching the portion of the stomach wall to actively create a feeling of satiety in the patient.

A surgical anchor device for being anchored on the mucous membrane of the inner wall of the intestine, the device having a temporary anchor element presenting anchoring that can be modified in a controlled manner and having a first substantially cylindrical multiply-perforated wall presenting properties of radial elasticity whereby the first wall presents an outer diameter that can be varied in controlled manner, wherein a portion of the inner surface of the first wall is lined with an independent leakproof inner sheath having only its longitudinal ends fastened to the anchor element to define a suction chamber between the inner sheath and the first wall, the temporary anchor element being coupled to a flexible or semi-rigid tube extending outside the anchor element, an open end of the injection-suction tube opening out into the suction chamber enabling air to be injected into or sucked out from the suction chamber.

A device for treating obesity of a patient, the device comprising: at least one operable stretching device implantable in the patient and adapted to stretch a portion of the patient's stomach wall, and an implantable control unit for automatically controlling the operable stretching device, when the control unit and stretching device are implanted, to stretch the stomach wall portion in connection with the patient eating such that satiety is created.

Herein disclosed are methods of using nasal inserts for various different ailments. Easy modification of the insert allows for treatment of various ailments that can readily be treated via the nose, such as ailments triggered by smell. Specifically, the insert can direct air into or out of the nasal cavity and/or delivers medicinal substances to the appropriate regions, thereby providing the appropriate therapeutic effect, depending on the ailment being treated.

A surgical anchor device for being anchored on the mucous membrane of the inner wall of the intestine, the device having a temporary anchor element presenting anchoring that can be modified in a controlled manner and having a first substantially cylindrical multiply-perforated wall presenting properties of radial elasticity whereby the first wall presents an outer diameter that can be varied in controlled manner, wherein a portion of the inner surface of the first wall is lined with an independent leakproof inner sheath having only its longitudinal ends fastened to the anchor element to define a suction chamber between the inner sheath and the first wall, the temporary anchor element being coupled to a flexible or semi-rigid tube extending outside the anchor element, an open end of the injection-suction tube opening out into the suction chamber enabling air to be injected into or sucked out from the suction chamber.

Devices and methods of endolumenal formation of gastric sleeves are described. Some embodiments allow templating of a gastric sleeve by a gastric bougie, exposing a selected amount of tissue for suturing access, while maintaining sufficient internal working space for suturing within the template lumen.

The present invention relates to a reflux disease treatment apparatus, comprising two or more movement restriction device segments adapted to form an implantable movement restriction device with an elongated shape that maintains cardia in the correct position. The movement restriction device has proximal and a distal end, wherein the distal end is adapted to stabilize and hold the proximal end. The invention further comprises a control device for controlling the stimulation device to stimulate the cardia sphincter. The distal end can be further adapted to treat obesity, for example by stretching the wall of the stomach or filling out a volume of the stomach.

A bariatric device and procedure configured to control the amount of food and nutrients entering a person's duodenum and reduce the weight of the person, in one aspect, comprises a gastrostomy tube having a proximal end and a distal end; a feeding tube assembly, said assembly including a feeding tube having a proximal end and a distal end; a gastrostomy tube anchor for securing the distal end of said gastrostomy tube inside the stomach; and a first feeding tube anchor designed to be expanded after the pyloric sphincter so as to anchor the distal end of said feeding tube in the duodenum.

An intraluminar method of treating obesity of a patient, having a stomach with a food cavity, is disclosed. The method comprises the steps of creating a pouch made of a stomach wall portion of the patient, closing the pouch by sutures, staples or a fixation device, and placing a volume filling device in the pouch before or after closing the pouch, and thus investigating the volume filling device in the pouch such that an outer surface of the volume filling device rests against an outer surface of the stomach wall.

Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspension of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.